Bacterial extract (OM-85) with human-equivalent doses does not inhibit the development of asthma in a murine model
- 1 November 2016
- journal article
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 44 (6) , 504-511
Abstract
OM-85 is an immunostimulant bacterial lysate, which has been proven effective in reducing the number of lower airways infections. We investigated the efficacy of the bacterial lysate OM-85 in the primary prevention of a murine model of asthma. In the first phase of our study the animals received doses of 0.5μg, 5μg and 50μg of OM-85 through gavage for five days (days -10 to -6 of the protocol), 10 days prior to starting the sensitisation with ovalbumin (OVA), in order to evaluate the results of dose-response protocols. A single dose (5μg) was then chosen in order to verify in detail the effect of OM-85 on the pulmonary allergic response. Total/differential cells count and cytokine levels (IL-4, IL-5, IL-13 and IFN-γ) from bronchoalveolar lavage fluid (BALF), OVA-specific IgE levels from serum, lung function and lung histopathological analysis were evaluated. OM-85 did not reduce pulmonary eosinophilic response, regardless of the dose used. In the phase protocol using 5μg/animal of OM-85, no difference was shown among the groups studied, including total cell and eosinophil counts in BALF, serum OVA-specific IgE, lung histopathologic findings and lung resistance. However, OM-85 decreased IL-5 and IL-13 levels in BALF. OM-85, administered in early life in mice in human-equivalent doses, does not inhibit the development of allergic pulmonary response in mice.Keywords
This publication has 24 references indexed in Scilit:
- Early-life viral infections and the development of asthmaCurrent Opinion in Allergy and Clinical Immunology, 2014
- Probiotics and Lung Immune ResponsesAnnals of the American Thoracic Society, 2014
- Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysisBMJ, 2013
- Probiotic Administration in Early Life, Atopy, and Asthma: A Meta-analysis of Clinical TrialsPediatrics, 2013
- The immunostimulant OM-85 BV prevents wheezing attacks in preschool childrenJournal of Allergy and Clinical Immunology, 2010
- Can we prevent exacerbations of asthma caused by common cold viruses?Journal of Allergy and Clinical Immunology, 2010
- Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma controlMucosal Immunology, 2010
- Do early-life viral infections cause asthma?Journal of Allergy and Clinical Immunology, 2010
- Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age ChildrenNew England Journal of Medicine, 2002
- The common mucosal immune system and current strategies for induction of immune responses in external secretionsJournal of Clinical Immunology, 1987